During the past three decades since its invention, the polymerase chain reaction method (PCR) has become a fundamental method for analysis in life sciences. While developed countries still dominate the PCR market, emerging markets are showing strong growth trends.
A September study from Acubiz Consulting titled The Asia Pacific Markets for PCR Technologies identifies market dynamics in various countries in the Asia Pacific (APAC) region and forecasts the potential of the market related to product segments, technology segments, and end-use segments.
The global demand for PCR was around US$10.6 billion in 2013. Even though North America had the highest market share in 2013, the Asia Pacific region is forecast to grow at a CAGR of over 11% between 2013 and 2018.
The application segments of this platform are still expanding, driven by the expiry of key PCR patents. The rising investments in the field of companion diagnostics have also been boosting the demand for PCR. Food safety testing is another significant end-use segment of the technology, driven by both consumer demand and regulatory requirements. Identifying the animal origin of meat products is another application.
Companies featured in this report include Abbott Laboratories,
Arachem, Cepheid, Fisher Biotec, KogeneBiotech and Seegene.